Antiplatelet Medications: Old and Emerging Therapies

William M. Stone, Sailendra G. Naidu, Alyssa Chapital, Samuel R. Money

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


Antiplatelet medications have been proven to enhance outcomes in patients with cardiovascular disease. The ideal platelet inhibitor would be quick and reversible and would have universal response, an excellent safety profile, and proven benefit. Currently available antiplatelet medications have been demonstrated to have variable patient response. In light of this medication resistance, emerging therapies to inhibit platelet aggregation are under investigation. We review the currently available antiplatelet medications and the current state of these emerging therapies.

Original languageEnglish (US)
Pages (from-to)140-148
Number of pages9
JournalAnnals of Vascular Surgery
Issue number1
StatePublished - Jan 2010

ASJC Scopus subject areas

  • Surgery
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Antiplatelet Medications: Old and Emerging Therapies'. Together they form a unique fingerprint.

Cite this